Skip to main content
. 2007 Aug 29;176(12):1200–1207. doi: 10.1164/rccm.200707-980OC

TABLE 3.

MULTIVARIATE MEAN DIFFERENCES IN FEV1, PERCENTAGE OF EMPHYSEMA, AND DIFFUSING CAPACITY PER 1 SD CHANGE IN FLOW-MEDIATED DILATION OF THE BRACHIAL ARTERY IN FORMER SMOKERS

Former Smokers (n = 107)
Former Smokers without COPD (n = 63)
Difference in Lung Measure per 1 SD Change in FMD (95% CI) P Value Difference in Lung Measure per 1 SD Change in FMD (95% CI) P Value
Post-bronchodilator FEV1, ml
 Model 1* 147 (31, 264) 0.015 148 (55, 241) 0.003
 Model 2 148 (34, 263) 0.013 151 (57, 245) 0.003
 Model 3 132 (16, 248) 0.029 107 (7, 207) 0.042
CT percentage of emphysema
 Model 1* −2.5 (−4.8, −0.1) 0.041 −2.3 (−5.3, 0.7) 0.144
 Model 2 −2.5 (−4.9, −0.1) 0.046 −2.4 (−5.3, 0.6) 0.128
 Model 3 −2.6 (−4.7, −0.5) 0.018 −3.5 (−6.1, −0.8) 0.017
DlCO, ml/min/mm Hg
 Model 1* 0.708 (−0.088, 1.505) 0.085 0.399 (−0.304, 1.103) 0.271
 Model 2 0.712 (−0.087, 1.511) 0.084 0.387 (−0.330, 1.104) 0.295
 Model 3 0.708 (−0.088, 1.504) 0.088 0.461 (−0.319, 1.240) 0.254

Definition of abbreviations: CI = confidence interval; COPD = chronic obstructive pulmonary disease; CT = computed tomography; FMD = flow-mediated dilation.

*

Model 1 adjusted for age, sex, race/ethnicity, and height.

Model 2 adjusted for age, sex, race/ethnicity, height, and pack-years.

Model 3 adjusted for age, sex, race/ethnicity, height, pack-years, educational attainment, asthma, body mass index, diabetes, hypertension, hypercholesterolemia, and use of statins, aspirin, β-blockers, omega-3 supplements, and postmenopausal hormones.